{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1222, 
        1228
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1249, 
        1256
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1229, 
        1238
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1257, 
        1266
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1019, 
        1042
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1099, 
        1126
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1128, 
        1132
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2884, 
        2888
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        565, 
        594
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2080, 
        2115
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2856, 
        2882
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1213, 
        1221
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1246, 
        1247
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1133, 
        1139
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2889, 
        2895
      ]
    }
  ], 
  "Relative Distance (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2908, 
        2912
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1146, 
        1155
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2901, 
        2905
      ]
    }
  ], 
  "Supplementary Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1820, 
        1852
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1084007^CLIA|eMARCPlus|TN Cancer Registry|20170919125832||ORU^R01^ORU_R01|201709191258320001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-55-004942^PathSys^44D1084007^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170831000000|||||||20170831000000|&Breast, Stereotactic biopsy|1861486797^^^^^^MD^^CMS^D^^^NPI||||||20170901000000|||F||||||C50.812^Malignant neoplasm of overlapping sites of left female breast^I10~Z17.0^Estrogen receptor positive status [ER+]^I10|1285672592&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe patient's name is \"\" identified by requisition and specimen container label. Received in formalin in a container labeled with the patient's name and \"left breast\" are six 0.3 to 1.1 cm long cores of yellow-tan and red-brown tissue with diameters varying from less than 0.1 to 0.1 cm. The specimen is submitted in its entirety in cassette 1A. NOTE: Specimen is in formalin greater than 6 and less than 72 hours. (JDM)\n\n\nPath report.relevant Hx\n\nHistory - Left breast mass, architectural distortion\n\n\nPath report.final diagnosis\n\nLeft breast core, 9-o'clock, 9 cm from the nipple, 4 cm from the sternum (biopsy):   Invasive ductal carcinoma, grade 1 (tubular carcinoma) Breast Prognostic Panel Immunohistochemical stains for Ki-67, p53, estrogen receptor and progesterone receptor, and HER-2/neu have been performed on formalin fixed paraffin embedded tissue. Positive and negative controls react appropriately. The results are as follows  Estrogen Receptor (SP1): 3+ nuclear staining, 100% of nuclei Progesterone Receptor(1E2): 3+ nuclear staining, 100% of nuclei Ki-67(30-9): <10% of nuclei (Low labeling index) P53(Bp53-11): 0+ nuclear staining, 100% of nuclei (negative) Her2: 1+ Please see microscopic description.\n\n\nPath report.supplemental reports\n\nPreliminary Report: Left breast core, 9-o'clock, 9 cm from the nipple, 4 cm from the sternum (biopsy):   Invasive ductal carcinoma, grade 1.   Final diagnosis pending prognostic marker studies. ## End of auxiliary report ##\n\n\nPath report.microscopic examination\n\nHer2/neu Immunohistochemistry Report  Block: 1A  Specimen Site:left breast  Specimen Tye: needle biopsy  Fixative: Formalin  Time to fixation: Unavailable  Duration of fixation: 11 hours  Antibody used: Clone 4B5 (Ventana), on Ventana Benchmark.  Controls: high protein expression,  Adequacy of sample for evaluation: Adequate Results:  Percentage of invasive tumor cells exhibiting  complete membrane staining: 0 Uniformity of staining: absent Homogeneous, dark circumferential staining: absent Interpretation: Negative for HER2 protein overexpression. This quantitative immunohistochemical evaluation of Human Epidermal Growth Factor 2 (HER-2) is performed in accordance with all current guidelines as recommended by the ASCO and CAP.\n\n\nPath report.site of origin\n\nLeft breast core 9:00 - 9 cm from the nipple, 4 cm from sternum\n\n\n"
}